Use of lipid conjugates in the treatment of diseases associated with vasculature

Details for Australian Patent Application No. 2010247105 (hide)

Owner Yissum Research Development Company of the Hebrew University of Jerusalem Ltd.

Inventors Yedgar, Saul

Agent Davies Collison Cave

Pub. Number AU-A-2010247105

PCT Pub. Number WO2010/131116

Priority 12/463,792 11.05.09 US

Filing date 11 May 2010

Wipo publication date 18 November 2010

International Classifications

A61K 31/726 (2006.01) - Glycosaminoglycans, i.e. mucopolysaccharides

A61K 31/727 (2006.01)

A61K 31/728 (2006.01)

A61K 38/17 (2006.01) Medicinal preparations containing peptides - from animals

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

A61P 35/00 (2006.01) Antineoplastic agents

C12N 5/00 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines

Event Publications

1 December 2011 PCT application entered the National Phase

  PCT publication WO2010/131116 Priority application(s): WO2010/131116

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010247117-Splicing system

2010247101-Smoking room with the air renewed by a laminar flow